Denali Therapeutics Inc. [DNLI] has reported $330.5 million in revenue for year ended Dec 31, 2023.
Also Read:
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $145,224,000.0 .
Also Read:
Based in South San Francisco, California, Denali Therapeutics Inc. operates in the Manufacturing sector.
Related Articles: